A closer look at the comparator drug sourcing supply chain
By World Courier
Supply chain disruptions, transport restrictions, and the expedited development of vaccines — as a result of COVID-19 — all create challenges within the comparator sourcing process
This paper shows how innovation, and relentless focus on flawless execution, can minimize the impact of macro events on clinical trials. Using the current pandemic as a reference, these challenges include sourcing and transporting comparator drugs, comedications, rescue medications (both branded and generic), and other ancillary supplies.
This white paper is a must-read for leaders within R&D, supply chain, procurement, and quality assurance at clinical trial sponsors and CDMOs, and other management and research organizations.
